Document is current
Any future updates will be listed below
-
Authors
Kady, Mohamed R. https://orcid.org/0000-0003-1568-6394
Elston, R. Nicholas https://orcid.org/0009-0003-6855-9476
Snyder, Lauren J. https://orcid.org/0009-0005-8173-0367
Fleischman, Jorie D. https://orcid.org/0009-0005-7243-3950
Brandt, Madilyn J. https://orcid.org/0009-0007-0475-0748
Zhu, Duolong https://orcid.org/0000-0002-8048-2171
Britton, Robert A. https://orcid.org/0000-0001-8983-9539
Beeton, Christine https://orcid.org/0000-0002-2500-5874
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (F30 AI181286, R01 AI173318)
National Heart, Lung, and Blood Institute (T32 HL170967)
U.S. Department of Defense (W81XWH-22-1-0036)
- License Information
-
More Information
Article History
Received: 28 March 2025
Accepted: 17 July 2025
First Online: 2 August 2025
Declarations
:
: All animal experiment protocols were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine.
: Not applicable.
: CB is an inventor on the patent protecting ShK-186, currently in clinical trials for the treatment of autoimmune diseases. CB and RAB are inventors on a patent disclosure protecting LrS235. RAB is a cofounder of Mikrovia and PanaBio.
